adagrasib

FDA Drug Profile — KRAZATI

adagrasib is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including KRAZATI. Available dosage form: tablet, coated.

Drug details

Generic Name
adagrasib
Brand Names
KRAZATI
Application Number
NDA216340
Sponsor
Mirati Therapeutics, Inc
NDC Codes
3
Dosage Forms
TABLET, COATED
Routes
ORAL
Active Ingredients
ADAGRASIB

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.